PAR 3.57% 27.0¢ paradigm biopharmaceuticals limited..

Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial, page-14

  1. 311 Posts.
    lightbulb Created with Sketch. 34
    I read the results and I cannot see what all the negativity is about
    They are very good results
    Admittedly it is not a real game changer for shareholders but great news for sufferers and it may likely trigger action in the deal space
    This is testimony that it has multi uses
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
27.0¢
Change
-0.010(3.57%)
Mkt cap ! $94.44M
Open High Low Value Volume
28.0¢ 29.0¢ 27.0¢ $127.7K 460.1K

Buyers (Bids)

No. Vol. Price($)
12 287444 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 100870 1
View Market Depth
Last trade - 16.10pm 17/05/2024 (20 minute delay) ?
Last
27.0¢
  Change
-0.010 ( 5.69 %)
Open High Low Volume
28.5¢ 29.0¢ 27.0¢ 132157
Last updated 15.59pm 17/05/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.